Prostate cancer decisions — 2019

The Veteran's tinnitus claim is remanded for a new VA examination. The prostate cancer residuals reduction from 40 to 20 percent effective December 31, 2018, requires issuance of an SOC.

The Board has remanded the Veteran's claims for service connection due to unclear information about his exposure at Spesutie Island and Aberdeen Proving Grounds. The case will be referred to the Under Secretary for Health for a radiation dose assessment.

The Board has granted service connection for diabetes mellitus, prostate cancer, and leukemia on a presumptive basis due to herbicide exposure during the Veteran's active duty in Thailand.

The Veteran's claim for COPD was denied due to lack of evidence linking the condition to service. New evidence has not reopened this claim.,Prostate cancer and type II diabetes were granted as they are presumed conditions related to herbicide agent exposure during service in Vietnam.,Diabetic neuropathy of the bilateral upper and lower extremities is also granted, linked to the Veteran's service-connected type II diabetes.

The Veteran's appeal is remanded for the VA to obtain updated treatment records and schedule him for a VA examination to assess his service-connected radiation proctitis.

The Veteran's lung and prostate cancer are granted service connection as presumptively related to his in-service herbicide exposure during his active military service in Thailand.

Service connection for a left ankle disability is denied.,The petition to reopen the previously denied claim of entitlement to service connection for hypertension is denied. New and material evidence has not been received to reopen this claim.,Entitlement to service connection for residuals of prostate cancer, to include as due to exposure to ionizing radiation, is remanded.

The Board has granted service connection for residuals of prostate cancer and diabetes mellitus, type II, as secondary to in-service herbicide exposure.

The Veteran's claim for hypertension was reopened due to the submission of new and material evidence. Service connection for hypertension is granted.,For prostate cancer, an increased rating in excess of 20 percent prior to November 5, 2016, and in excess of 30 percent beginning from that date, is denied.

The Veteran's claims for service connection for COPD and prostate cancer have been reopened, but the Board has determined that additional development is needed before a decision can be made.

The Veteran's prostate cancer is granted service connection due to presumed exposure to herbicide agents. The initial rating for cluster headaches and the service connection for nonspecific pulmonary nodules are both remanded.

The Board denied service connection for prostate cancer, CLL, and thyroid cancer residuals due to lack of evidence linking these conditions to the Veteran's military service.

The Veteran's back disability and prostate cancer were not granted service connection. The claim for prostate cancer was reopened, but the grant of service connection is based on presumptive exposure to herbicide agents.

The Veteran's appeals for service connection for various conditions, including prostate cancer and melanoma, are dismissed due to the death of the appellant.

The Veteran's appeal has been withdrawn due to his request for a withdrawal of the appeal. As such, no further action will be taken on these issues.

The Veteran's service connection claims for diabetes mellitus, prostate cancer, and ischemic heart disease are granted due to presumed exposure to herbicide agents while stationed at U-Tapao Royal Thai Air Force Base in Thailand.

The Veteran's death was caused by metastatic lung cancer, which is not service-connected. The Board found no evidence linking the Veteran's conditions to his active service.

The Board has decided to remand the case due to insufficient information in the previous VA opinion regarding the Veteran's claim for compensation under 38 U.S.C. § 1151.

The Veteran's service connection claims for prostate cancer, psychiatric disorder, and ischemic heart disease are granted due to exposure to herbicide agents during his service in Thailand. The Board found that the Veteran was exposed to herbicides based on his MOS as a corrosion control specialist and his work area near the base perimeter.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence of herbicide exposure and no chronic disease manifestation within one year after service. The Veteran's claim is therefore denied.